FIELD: medicine, endocrinology. SUBSTANCE: invention proposes a method of treatment of vascular complications caused by metabolic syndrome in diabetes mellitus of type-2. Method involves administration of 2-ethyl-6-methyl-3-hydroxypyridine succinate as a capsulated form in the dose 0.1 g, 3 times per 24 h for 2 months or as an injection form in the dose 0.1 g, 2 times per 24 h for 7-14 days. Method provides decrease of vessels damage progression in diabetes mellitus. EFFECT: enhanced effectiveness of agent. 1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIOXIDANT, ANTIHYPERGLYCEMIC, HYPOLIPIDEMIC AND ANTISHOCK N-ACETYLCYSTEINATE 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE | 2006 |
|
RU2357955C2 |
| METHOD FOR EVALUATING OXIDATIVE STRESS IN METABOLIC SYNDROME | 2021 |
|
RU2763478C1 |
| METHOD OF TREATING CRITICAL ISCHEMIA OF LOWER EXTREMITIES OF VARIOUS GENESES | 2010 |
|
RU2421221C1 |
| PREPARATION FOR NORMALISATION OF LIPID PEROXIDATION PROCESSES IN ANIMALS | 2013 |
|
RU2538666C2 |
| METHOD FOR CORRECTION OF LIPID PEROXIDATION PROCESSES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2016 |
|
RU2627458C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF MECHANICAL JAUNDICE OF MALIGNANT GENESIS | 2020 |
|
RU2738310C1 |
| METHOD FOR NORMALIZING THROMBOCYTIC DISORDERS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268046C1 |
| METHOD OF DECREASED THROMBOCYTE ACTIVITY IN PATIENTS SUFFERING FROM METABOLIC SYNDROME | 2007 |
|
RU2345764C2 |
| METHOD AND BIOSTIMULATION MEANS FOR TREATING SOMATIC DISEASES | 1999 |
|
RU2149013C1 |
| METHOD FOR CORRECTING THROMBOCYTIC DYSFUNCTIONS IN CASE OF METABOLIC SYNDROME | 2004 |
|
RU2268041C1 |
